Method and apparatus for delaying a ventricular tachycardia therapy

• US 20060089675A1
• Filed: 12/12/2005
• Published: 04/27/2006
• Est. Priority Date: 04/26/2002
• Status: Active Grant

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Burnes, John E., Degroot, Paul J.
• Granted Patent: US 7,474,920 B2
• Time in Patent Office: Days
• US Class Current: 607/4
• CPC Class Codes: A61N 1/3621 for treating or preventing abnormally high heart rate
• CPC Class Codes: A61N 1/39622 Pacing therapy

Abstract

A device and method to detect slow ventricular tachycardia, deliver anti-tachycardia pacing therapies, and delay a scheduled shock therapy if the ventricular tachycardia is not terminated or accelerated. Preferably, a shock therapy is delayed after verifying hemodynamic stability based on a hemodynamic sensor. After a shock is delayed, the device operates in a high alert mode for redetecting an accelerated tachycardia. Anti-tachycardia pacing therapies are repeated during the shock delay. A number of conditions can trigger delivery of the delayed shock therapy including a specified period of elapsed time; determination that the patient is likely to be asleep; detection of myocardial ischemia; detection of compromised hemodynamics, or detection of a substantially prone position or sudden change in position. A delayed shock therapy may be triggered by the patient and repeated delivery of painful shock therapies in patients that are not seriously compromised by a recurring, slow ventricular tachycardia is avoided.

Claims

1. A method for controlling the delivery of a shock therapy in a cardiac patient experiencing ventricular tachycardia, comprising:

detecting a ventricular tachycardia;

delivering an anti-tachycardia pacing therapy when said ventricular tachycardia is detected;

determining if the ventricular tachycardia is terminated after said anti-tachycardia pacing therapy is delivered; and

delaying a programmed shock therapy based on measures of hemodynamic state.

2. The method of claim 1 wherein said measures of hemodynamic state included setting a hemodynamic threshold criteria.

3. The method according to claim 2 wherein said measure of hemodynamic threshold state includes setting a hemodynamic stable state.

4. The method of claim 1, further comprising:

setting a hemodynamic threshold criteria;

detecting a hemodynamic state of the patient; and

delaying said programmed therapy based or comparing said hemodynamic state of the patient against said hemodynamic threshold criteria.

5. The method of claim 4 wherein said method further comprising:

defining a condition for delivering a delayed shock therapy; and

delivering said delayed shock therapy when the condition for shock delivery is satisfied.

6. The method of claim 5 wherein said condition for delivering a delayed shock therapy includes detecting a hemodynamic state that does not meet said hemodynamic threshold criteria.

7. The method according to claim 5 wherein said condition for delivering a delayed shock therapy includes monitoring a specified amount of elapsed time.

8. The method according to claim 1 further comprising:

defining a condition for delivering a delayed shock therapy; and

delivery said delayed shock therapy when said condition for delivering is satisfied.

9. The method according to claim 8, further including detecting a posture of the patient.

10. The method according to claim 9 wherein said condition for delivering a shock therapy includes detection of a sudden change in the patient'"'"'s position.

11. The method of claim 8 further including detecting a sleeping state of the patient.

12. The method of claim 11 wherein a condition for delivering said delayed shock therapy includes detection of a sleeping state.

13. The method of claim 8 further including detecting myocardial ischemia.

14. The method of claim 8 wherein shock therapy is delivered by the patient or physician.

15. A device-implemented software system for controlling the delivery of a shock therapy in a cardiac patient experiencing ventricular tachycardia, the system comprising:

means for detecting a ventricular tachycardia;

means for identifying if slow ventricular tachycardia is detected;

means for delivering programmed anti-tachycardia pacing therapies;

means for detecting termination of the ventricular tachycardia;

means for sustained redetection of slow ventricular tachycardia;

means for checking hemodynamic instability;

means for delaying programmed shock therapy; and

means for generating patient notification.

16. The system of claim 15 wherein said means for detecting termination further cooperates with means for checking sustained slow ventricular tachycardia.

17. The system of claim 16 wherein said means for detecting hemodynamic instability cooperates with means for detecting myocardial ischemia, means for detecting sleep, means for marking predetermined time elapsed and means for confirming if one of shock conditions met and shock conditions not met.

18. The system of claim 15 wherein said means for generating patient notification further includes means for signaling a high alert mode.